Atlas Trials

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

Clinical trial NCT07204366 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07204366
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Myeloproliferative DiseaseCOVID - 19
Start date
2022-05-06
Primary completion
2030-12-31
Enrollment
219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.